Drug Search Results
More Filters [+]

Balofloxacin

Alternative Names: balofloxacin
Latest Update: 2023-02-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Korea

Approved Indications: None

Known Adverse Events: None

Company: Yuekang Pharmaceutical Group Co., Ltd./Hefei Xinfeng Technology Development Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Balofloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20132310

N/A

Completed

Serratia Infections|Pseudomonas Infections|Escherichia coli Infections|Urethritis|Proteus Infections|Klebsiella Infections|Cystitis|Urinary Tract Infections

2013-11-01

Recent News Events